Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT) (ZU-HVA-001)

This study has been completed.
Information provided by:
University of Zurich Identifier:
First received: August 27, 2008
Last updated: August 18, 2010
Last verified: September 2008
In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Condition Intervention Phase
Hymenoptera Sting Allergy
Other: Observation
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects

Further study details as provided by University of Zurich:

Estimated Enrollment: 200
Study Start Date: August 2008
Study Completion Date: August 2010
Groups/Cohorts Assigned Interventions
Hymenoptera sting allergic patients under immunotherapy
Other: Observation
Observation of sting frequency


Ages Eligible for Study:   5 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Hymenoptera sting allergic patients under allergen specific immunotherapy

Inclusion criteria:

  • Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00742794

Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: G.Senti, University of Zurich Identifier: NCT00742794     History of Changes
Other Study ID Numbers: ZU-HVA-001
Study First Received: August 27, 2008
Last Updated: August 18, 2010

Additional relevant MeSH terms:
Bites and Stings
Chemically-Induced Disorders
Wounds and Injuries processed this record on April 26, 2017